2022
DOI: 10.3390/pharmaceutics14071498
|View full text |Cite
|
Sign up to set email alerts
|

Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier Disruption

Abstract: The management of brain diseases remains a challenge, particularly because of the difficulty for drugs to cross the blood–brain barrier. Among strategies developed to improve drug delivery, nano-sized emulsions (i.e., nanoemulsions), employed as nanocarriers, have been described. Moreover, focused ultrasound-mediated blood–brain barrier disruption using microbubbles is an attractive method to overcome this barrier, showing promising results in clinical trials. Therefore, nanoemulsions combined with this techno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 70 publications
0
5
0
Order By: Relevance
“…However, a smaller mean diameter and lower PDI were achieved here with a simpler and more cost-effective approach, with a low-boiling-point (C 4 F 10 ) core. Importantly, the additional size-isolation step of the parent MBs appears to lower the resultant ND polydispersity index (values of 0.1–0.4 have been reported ,, ) and eliminates the formation of droplets larger than 0.5 μm in diameter that have been reported with the conventional condensation approach of polydisperse precursor MBs . Achieving a small size and narrow size distribution of NDs is important, as these factors strongly influence ND behavior in vivo , including circulation time, organ retention, extravasation, as well as vaporization threshold and conversion efficiency. ,, The importance extends beyond vaporization, as the acoustic response of the resultant MB population after conversion similarly depends on size and size distribution, and a more narrow MB distribution can be expected to have a more homogeneous response to the incident ultrasound. ,, …”
Section: Resultsmentioning
confidence: 99%
“…However, a smaller mean diameter and lower PDI were achieved here with a simpler and more cost-effective approach, with a low-boiling-point (C 4 F 10 ) core. Importantly, the additional size-isolation step of the parent MBs appears to lower the resultant ND polydispersity index (values of 0.1–0.4 have been reported ,, ) and eliminates the formation of droplets larger than 0.5 μm in diameter that have been reported with the conventional condensation approach of polydisperse precursor MBs . Achieving a small size and narrow size distribution of NDs is important, as these factors strongly influence ND behavior in vivo , including circulation time, organ retention, extravasation, as well as vaporization threshold and conversion efficiency. ,, The importance extends beyond vaporization, as the acoustic response of the resultant MB population after conversion similarly depends on size and size distribution, and a more narrow MB distribution can be expected to have a more homogeneous response to the incident ultrasound. ,, …”
Section: Resultsmentioning
confidence: 99%
“…In this context, PFCs are inert organic compounds used as “artificial blood” that improve tissue oxygenation and have been widely used in the clinic for various purposes, including artificial blood substitution, organ preservation, ultrasound, and 19 F magnetic resonance imaging 27 , 28 . Perfluorooctylbromide (PFOB) used in this study stands out among PFCs for medical use as it is non-toxic, high stability, inertness, and an acceptable excretion profile 30 . Therefore, the PFC-based Gly-PFOBs nanoplatform presented in this study has desirable biocompatibility and holds great potential in clinical translation.…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, PFC nano-emulsions hold promise for being harnessed as a versatile magnetic resonance (MR) contrast agent. PFOB used in this study stands out among PFCs for medical use as it, non-toxic, high stability, inertness, possesses the unique property of being both hydrophobic and lipophobic, and has an acceptable excretion profile 30 .…”
Section: Introductionmentioning
confidence: 99%
“…Bérard et al developed perfluorooctyl bromide (PFOB) nanodroplets loaded with a hydrophobic molecule of interest (dye or drug) and administered them in healthy mice, combined with FUS-mediated BBB disruption using microbubbles. 414 Their results showed BBB permeabilization and delivery of nanodroplets to the FUS exposed hemisphere only (Fig. 19).…”
Section: Blood–brain Barriermentioning
confidence: 94%